drugset / Trial / NCT00456560

AV650 Drug-Drug Interaction Study

NCT00456560

Phase 1 Completed 30 enrolled Avigen
RandomizedParallel-groupOpen-label

Summary

The purpose of this study is to evaluate the effects that paroxetine and fluvoxamine have on the way the body distributes, breakdowns and eliminates AV650. In addition, information about any side effects that may occur will also be collected.

Timeline

Start
2007-04
Primary completion
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject AV650 Unknown 300 mg Oral
Subject Fluvoxamine Unknown
Subject Paroxetine Small molecule

Indications

No indication recorded.